INFI - Infinity Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
No. of Analysts4344
Avg. Estimate-0.25-0.43-0.93-1.57
Low Estimate-0.27-0.73-0.95-2.93
High Estimate-0.22-0.27-0.9-1.04
Year Ago EPS-0.46-0.21-0.61-0.93
Revenue EstimateCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
No. of Analysts3244
Avg. EstimateN/A14.85M19.25M29.68M
Low EstimateN/AN/AN/AN/A
High EstimateN/A29.7M65M118.7M
Year Ago SalesN/AN/A18.72M19.25M
Sales Growth (year/est)N/AN/A2.80%54.20%
Earnings History12/30/20163/30/20176/29/20179/29/2017
EPS Est.-0.57-0.27-0.2-0.21
EPS Actual-0.46-0.21-0.34-0.14
Difference0.110.06-0.140.07
Surprise %19.30%22.20%-70.00%33.30%
EPS TrendCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
Current Estimate-0.25-0.43-0.93-1.57
7 Days Ago-0.25-0.43-0.93-1.57
30 Days Ago-0.25-0.43-0.93-1.57
60 Days Ago-0.25-0.43-0.93-1.57
90 Days Ago-0.25-0.43-0.93-1.57
EPS RevisionsCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Down Last 90 DaysN/AN/AN/AN/A
Growth EstimatesINFIIndustrySectorS&P 500
Current Qtr.45.70%N/AN/A0.34
Next Qtr.-104.80%N/AN/A0.40
Current Year-52.50%N/AN/A0.17
Next Year-68.80%N/AN/A0.11
Next 5 Years (per annum)89.63%N/AN/A0.12
Past 5 Years (per annum)19.94%N/AN/AN/A